Healthcare Delivery

Dupilumab Clinically Effective Long Term for Moderate to Severe Pediatric Atopic Dermatitis

May 17th 2022, 7:45pm


Findings of the 52-week phase 3 LIBERTY AD PED-OLE trial showed dupilumab to have an adequate safety profile and incremental clinical benefit with continued use among pediatric patients with moderate to severe atopic dermatitis.

Study: In Severe Asthma, Benefits of At-Home Biologics Outweigh Disadvantages

May 17th 2022, 6:21pm


A survey of patients and health care providers found both groups favor at-home administration of biologics when possible.

Trends Show Uptake of SUD Treatment Has Room for Improvement

May 17th 2022, 6:00pm


On this episode of Managed Care Cast, we speak with one of the authors of a paper published this month in Health Affairs about the utilization of substance use disorder treatment (SUD) services between 2010 and 2019, and why more needs to be done to get more individuals into treatment.

Contributor: The Convergence of Value-Based Care and Lab Testing Growth

May 17th 2022, 5:15pm


Today, health plans are shifting dollars to more value-based contracts along with investments in population health management. Digitizing lab results across all care settings and unlocking the potential of lab values can help health plans reach the Triple Aim of improving the patient experience, improving the health of populations, and reducing the per-member cost of health care.

Protein Biomarkers May Indicate Early Kidney Impairment, Study Finds

May 17th 2022, 4:29pm


A cross-sectional analysis found that protein biomarkers were associated with estimated glomerular filtration rate, which may capture early kidney impairment.

RAND Report Assesses Hospital Prices Paid by Employers, Private Insurers

May 17th 2022, 4:00pm


The report details totals paid to hospitals by private insurers and providers and compares the sums with a Medicare benchmark.

HPV Rates Continue to Decline, New Data Suggest Herd Immunity Growing

May 16th 2022, 9:00pm


Experts warn, however, that human papillomavirus (HPV) vaccinations missed because of the COVID-19 pandemic could stymie this progress.

Greater Biologic Persistence, Adherence Achieved With Ixekizumab for Psoriasis

May 16th 2022, 7:45pm


Significantly greater persistence, adherence, and time on monotherapy was achieved with the use of ixekizumab vs the biologics adalimumab, etanercept, secukinumab, and ustekinumab, in the treatment of moderate to severe psoriasis.

Dupilumab Improves Lung Function, Asthma Attacks in Children With Atopic Comorbidities

May 16th 2022, 4:30pm


Dupilumab improved lung function and reduced severe asthma exacerbation rates in children with moderate to severe asthma with or without atopic comorbidities.

What We're Reading: FDA Addressing Baby Formula Imports; Nivolumab, Ipilimumab in Urothelial Carcinoma; Antibiotics Linked With IBD

May 16th 2022, 2:30pm


FDA to make an announcement regarding importation of baby formula; first-line use of nivolumab and ipilimumab vs standard of care chemotherapy fails to meet primary end point of overall survival in phase 3 CheckMate 901 trial; study finds link between antibiotic prescriptions and inflammatory bowel disease diagnosis in older adults.